Related references
Note: Only part of the references are listed.The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity
Jaime Ponce et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2015)
Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss
Violeta B. Popov et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2015)
Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding
Laura Folini et al.
ACTA DIABETOLOGICA (2014)
Serum Alanine Aminotransferase Independently Correlates with Intrahepatic Triglyceride Contents in Obese Subjects
Zheng Chen et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients
Masahiro Takihata et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2014)
The Effectiveness and Risks of Bariatric Surgery An Updated Systematic Review and Meta-analysis, 2003-2012
Su-Hsin Chang et al.
JAMA SURGERY (2014)
Endoscopic Duodenal-Jejunal Bypass Liner Rapidly Improves Plasma Parameters of Nonalcoholic Fatty Liver Disease
Charlotte de Jonge et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Evolving aspects of liver transplantation for nonalcoholic steatohepatitis
Michael Charlton
CURRENT OPINION IN ORGAN TRANSPLANTATION (2013)
Endoscopic Suturing for Transoral Outlet Reduction Increases Weight Loss After Roux-en-Y Gastric Bypass Surgery
Christopher C. Thompson et al.
GASTROENTEROLOGY (2013)
Effectiveness of Intragastric Balloon Treatment for Obese Patients: One-Year Follow-up After Balloon Removal
Chi-Ming Tai et al.
OBESITY SURGERY (2013)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study
Yin-Mei Lee et al.
GASTROINTESTINAL ENDOSCOPY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Shelley E. Keating et al.
JOURNAL OF HEPATOLOGY (2012)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
Christian Thoma et al.
JOURNAL OF HEPATOLOGY (2012)
Preoperative Weight Loss with Intragastric Balloon Decreases the Risk of Significant Adverse Outcomes of Laparoscopic Gastric Bypass in Super-Super Obese Patients
Carlos Zerrweck et al.
OBESITY SURGERY (2012)
Smart Self-Assembling MagnetS for ENdoscopy (SAMSEN) for transoral endoscopic creation of immediate gastrojejunostomy
Marvin Ryou et al.
GASTROINTESTINAL ENDOSCOPY (2011)
A pathway to endoscopic bariatric therapies
Gregory G. Ginsberg et al.
GASTROINTESTINAL ENDOSCOPY (2011)
Endpoints and clinical trial design for nonalcoholic steatohepatitis
Arun J. Sanyal et al.
HEPATOLOGY (2011)
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings
Elizabeth M. Brunt et al.
HEPATOLOGY (2011)
Time-course of Changes of Visceral Fat Area, Liver Volume and Liver Fat Area during Intragastric Balloon Therapy in Japanese Super-obese Patients
Yusuke Sekino et al.
INTERNAL MEDICINE (2011)
Obesity 1 The global obesity pandemic: shaped by global drivers and local environments
Boyd A. Swinburn et al.
LANCET (2011)
Obesity Treatment Using a Bioenterics Intragastric Balloon (BIB)-Preliminary Croatian Results
Marko Nikolic et al.
OBESITY SURGERY (2011)
Intragastric Balloon Treatment for Obesity: Results of a Large Single Center Prospective Study
Davor Stimac et al.
OBESITY SURGERY (2011)
Obesity and bariatrics for the endoscopist: new techniques
Barham K. Abu Dayyeh et al.
Therapeutic Advances in Gastroenterology (2011)
Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients
Rosario Forlano et al.
GASTROINTESTINAL ENDOSCOPY (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis
Matthew Martin et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2010)
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
Philippe Mathurin et al.
GASTROENTEROLOGY (2009)
Metabolic parameters after BioEnterics Intragastric Balloon placement in obese patients
F. Donadio et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
G. A. Bray et al.
LANCET (2009)
Bariatric Therapy with Intragastric Balloon Improves Liver Dysfunction and Insulin Resistance in Obese Patients
Giorgio Ricci et al.
OBESITY SURGERY (2008)
Evidence-based Review of the Bioenterics Intragastric Balloon for Weight Loss
Jean-Marc Dumonceau
OBESITY SURGERY (2008)
Safety and effectiveness of the intragastric balloon for obesity.: A meta-analysis
Inaki Imaz et al.
OBESITY SURGERY (2008)
Revisional bariatric surgery for failed restrictive procedures
Brian A. Coakley et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2008)
Relationship of liver enzymes to insulin sensitivity and Intraw-abdominal fat
Tara M. Wallace et al.
DIABETES CARE (2007)
Effects of bariatric surgery on mortality in Swedish obese subjects
Lars Sjostrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk - The Framingham Heart Study
Douglas S. Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome
Jiko Yamada et al.
ATHEROSCLEROSIS (2006)
Weight loss and non-alcoholic fatty liver disease: Falls in gamma-glutamyl transferase concentrations are associated with histologic improvement
John B. Dixon et al.
OBESITY SURGERY (2006)
Hepatic steatosis and insulin resistance: Does etiology make a difference?
A Lonardo et al.
JOURNAL OF HEPATOLOGY (2006)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids
C Thamer et al.
HORMONE AND METABOLIC RESEARCH (2005)
Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome
G Marchesini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
Obesity in adulthood and its consequences for, life expectancy: A life-table analysis
A Peeters et al.
ANNALS OF INTERNAL MEDICINE (2003)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
